Complete Genomics Announces Shipment of Approximately 3,000 Genomes in 2011
News Jan 10, 2012
The company delivered more than 600 genomes to its customers in the fourth quarter of 2011. The company had earlier projected delivering approximately 900 genomes to its customers in the fourth quarter of 2011 but nearly 300 genomes took longer to move through the pipeline than anticipated and will ship in the first quarter of 2012.
"We are entering 2012 with a strong order book of about 5,800 genomes valued at approximately $28 million," noted Dr. Clifford Reid, chairman, president, and CEO of Complete Genomics. "We believe that our recent lab expansion will give us the capacity to handle both our current orders and anticipated new sales."
"We're pleased that researchers all over the world are recognizing the value of our turnkey service and quality of our sequenced genomes," Dr. Reid continued. "A recent Nature Biotechnology paper by Lam et al.,1 shows that our sequencing service provides variant data that leads the industry in accuracy."
In 2011, the company received orders for approximately 8,000 genomes valued at nearly $39 million.
Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.